Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Oncology (Williston Park). 2014 Oct;28(10):867–878.

TABLE 1.

Variant 1: Initial treatment for a 52-year-old male without a significant past medical history and an asymptomatic nonobstructing uT3N0 primary rectal tumor 8 cm from the anal verge and a solitary resectable 4 cm metastasis in the right lobe of the liver. KPS 90

Treatment Rating* Comments

Initial resection of rectal primary and liver lesion (either concurrent or sequential) 8
Initial systemic 5-FU-based chemotherapy (FOLFOX/FOLFIRI ± bevacizumab) 5
Initial preoperative pelvic RT + concurrent 5-FU-based chemotherapy 3
Resection of the liver lesion only 2
Best supportive care 1
*

Rating scale: 1–3, usually not appropriate; 4–6, may be appropriate; 7–9, usually appropriate.